AlphaFold predicted structure
CARS2 · Q9HA77

Mean pLDDT
86.1/ 100
Confident
564 residues
Confidence breakdown
- Very high(≥ 90)67%
- Confident(70–90)18%
- Low(50–70)6%
- Very low(< 50)10%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cysteinyl-tRNA synthetase 2, mitochondrial
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalCombined oxidative phosphorylation defect type 27
neurodegenerative disease
hereditary disease
atrial fibrillation
coronary artery disorder
temporomandibular joint disorder
Parkinson disease
nephritis
ovarian neoplasm
bone remodeling disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Probable cysteine--tRNA ligase, mitochondrial
Mitochondrial cysteine-specific aminoacyl-tRNA synthetase that catalyzes the ATP-dependent ligation of cysteine to tRNA(Cys)
CARS2 · Q9HA77

Mean pLDDT
86.1/ 100
Confident
564 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0